Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Subjects With Type 2 Diabetes Mellitus.”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT01009580
What this trial is testing

Comparison of NN5401 With Biphasic Insulin Aspart 30 in Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 447
Large-scale testing (Phase 3)Study completedNCT01572740
What this trial is testing

Efficacy and Safety of Liraglutide in Combination With Insulin Therapy Compared to Insulin Alone in Japanese Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 257
Not applicableStudy completedNCT04565418
What this trial is testing

Exercise to Restore 24h Rhythms in Metabolism

Who this might be right for
Diabetes Mellitus, Type 2Insulin Resistance
Maastricht University 10
Not applicableStudy completedNCT02598791
What this trial is testing

GIP/GLP-1 Co-Activity in Subjects With Obesity: Lowering of Food Intake

Who this might be right for
ObesityAdiposityType 2 Diabetes
University Hospital, Gentofte, Copenhagen 18
Early research (Phase 1)Study completedNCT01147718
What this trial is testing

A Drug Interaction Study of Albiglutide and Digoxin

Who this might be right for
Diabetes Mellitus, Type 2
GlaxoSmithKline 30
Early research (Phase 1)Study completedNCT01399346
What this trial is testing

Investigation of the Impact of Different Application Volumes of Insulin Aspart in Subjects With Type 1 Diabetes

Who this might be right for
Type 1 Diabetes
Medical University of Graz 12
Large-scale testing (Phase 3)Study completedNCT01682759
What this trial is testing

The Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 751
Early research (Phase 1)Study completedNCT02524782
What this trial is testing

A Phase 1, Single- and Multiple Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of MEDI4166 in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
MedImmune LLC 103
Large-scale testing (Phase 3)Ended earlyNCT01609582
What this trial is testing

Study of TAK-875 in Adults With Type 2 Diabetes and Cardiovascular Disease or Risk Factors for Cardiovascular Disease

Who this might be right for
Type 2 DiabetesCardiovascular Disease
Takeda 3,207
Testing effectiveness (Phase 2)Study completedNCT00842361
What this trial is testing

Comparison of NN5401 Versus Biphasic Insulin Aspart 30 on a Twice Daily Regimen in Subjects With Type 2 Diabetes Mellitus

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 66
Large-scale testing (Phase 3)Not Yet RecruitingNCT07487103
What this trial is testing

Efficacy and Safety of QLG1091 vs Rybelsus as add-on to Metformin in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes
Qilu Pharmaceutical Co., Ltd. 478
Not applicableStudy completedNCT04214704
What this trial is testing

Assessing the Benefits of a Painless Lancing Device Among Diabetes Patients

Who this might be right for
Type 1 DiabetesType 2 Diabetes
Jothydev's Diabetes and Research Centre 110
Not applicableUnknownNCT03787563
What this trial is testing

Herbal Tea in the Treatment of Type 2 Diabetes Mellitus

Who this might be right for
Type 2 Diabetes Mellitus
Composite Interceptive Med Science 10
Large-scale testing (Phase 3)Study completedNCT01527539
What this trial is testing

Long Term Safety and Efficacy of Biphasic Insulin Aspart 30 in Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 25
Not applicableStudy completedNCT00771680
What this trial is testing

Observational Study to Evaluate the Effectiveness and Safety of Levemir®, NovoMix® 30 and NovoRapid® in Insulin naïve Subjects With Type 2 Diabetes

Who this might be right for
DiabetesDiabetes Mellitus, Type 2
Novo Nordisk A/S 10,408
Large-scale testing (Phase 3)Study completedNCT01081834
What this trial is testing

The CANTATA-M (CANagliflozin Treatment and Trial Analysis - Monotherapy) Trial

Who this might be right for
Diabetes Mellitus, Type 2
Janssen Research & Development, LLC 678
Testing effectiveness (Phase 2)Study completedNCT02653599
What this trial is testing

Evaluate Safety and Efficacy of TTP273 for 12 Weeks in Subjects With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
vTv Therapeutics 174
Post-approval studies (Phase 4)Study completedNCT03089333
What this trial is testing

Effects of SGLT2 Inhibitor on Hemodynamic Parameters in Resistant Hypertensive Subjects

Who this might be right for
HypertensionDiabetes Mellitus, Type 2Blood Pressure+4 more
University of Campinas, Brazil 16
Large-scale testing (Phase 3)Study completedNCT01023581
What this trial is testing

Efficacy and Safety of Alogliptin Plus Metformin in Patients With Type 2 Diabetes

Who this might be right for
Diabetes Mellitus, Type 2
Takeda 784
Large-scale testing (Phase 3)Study completedNCT01755156
What this trial is testing

Evaluate the Safety, Tolerability, and Efficacy of the Addition of Omarigliptin (MK-3102) to Participants With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control on Metformin Therapy (MK-3102-024)

Who this might be right for
Type 2 Diabetes Mellitus
Merck Sharp & Dohme LLC 402
Next Page